Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016-19).


Journal

JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 02 06 2021
accepted: 07 07 2021
entrez: 21 10 2021
pubmed: 22 10 2021
medline: 22 10 2021
Statut: epublish

Résumé

The SENTRY Antimicrobial Surveillance Program monitors the frequency of occurrence and antimicrobial susceptibility of organisms from various infection types worldwide. To evaluate the SENTRY programme results for organisms isolated from respiratory samples of patients hospitalized with probable pneumonia. A total of 28 918 bacterial isolates were consecutively collected (one per patient) in 2016-19 from 121 medical centres located in western Europe (W-EU; Gram-negative bacilli (GNB) represented 76.3%, 88.6% and 69.1% of organisms; non-fermentative (NF) GNB accounted for 26.9%, 51.8% and 34.6% of organisms in W-EU, E-EU and USA, respectively. Rank order and antimicrobial susceptibility of bacteria isolated from patients with pneumonia widely varied by geography. MDR NF-GNB represented an important cause of pneumonia.

Sections du résumé

BACKGROUND BACKGROUND
The SENTRY Antimicrobial Surveillance Program monitors the frequency of occurrence and antimicrobial susceptibility of organisms from various infection types worldwide.
OBJECTIVES OBJECTIVE
To evaluate the SENTRY programme results for organisms isolated from respiratory samples of patients hospitalized with probable pneumonia.
METHODS METHODS
A total of 28 918 bacterial isolates were consecutively collected (one per patient) in 2016-19 from 121 medical centres located in western Europe (W-EU;
RESULTS RESULTS
Gram-negative bacilli (GNB) represented 76.3%, 88.6% and 69.1% of organisms; non-fermentative (NF) GNB accounted for 26.9%, 51.8% and 34.6% of organisms in W-EU, E-EU and USA, respectively.
CONCLUSIONS CONCLUSIONS
Rank order and antimicrobial susceptibility of bacteria isolated from patients with pneumonia widely varied by geography. MDR NF-GNB represented an important cause of pneumonia.

Identifiants

pubmed: 34671728
doi: 10.1093/jacamr/dlab117
pii: dlab117
pmc: PMC8522161
doi:

Types de publication

Journal Article

Langues

eng

Pagination

dlab117

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.

Références

Clin Infect Dis. 2016 Sep 1;63(5):e61-e111
pubmed: 27418577
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S1-S4
pubmed: 30895209
J Antimicrob Chemother. 2019 Jun 1;74(6):1595-1606
pubmed: 30843070
Euro Surveill. 2018 Oct;23(42):
pubmed: 30352641
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
J Intensive Care Med. 2010 Sep;25(5):259-70
pubmed: 20622257
J Antimicrob Chemother. 2020 Oct 1;75(10):2907-2913
pubmed: 32653914
Infect Control Hosp Epidemiol. 2020 Jan;41(1):1-18
pubmed: 31767041
Clin Infect Dis. 2014 Sep 15;59(6):798-807
pubmed: 24879783

Auteurs

Helio S Sader (HS)

JMI Laboratories, North Liberty, IA 52317, USA.

Jennifer M Streit (JM)

JMI Laboratories, North Liberty, IA 52317, USA.

Cecilia G Carvalhaes (CG)

JMI Laboratories, North Liberty, IA 52317, USA.

Michael D Huband (MD)

JMI Laboratories, North Liberty, IA 52317, USA.

Dee Shortridge (D)

JMI Laboratories, North Liberty, IA 52317, USA.

Rodrigo E Mendes (RE)

JMI Laboratories, North Liberty, IA 52317, USA.

Mariana Castanheira (M)

JMI Laboratories, North Liberty, IA 52317, USA.

Classifications MeSH